Furthermore, treatment of chemo and hormone therapy-resistant breast cancer with the SPHK2 inhibitor ABC294640 completely inhibited tumor volume, suggesting that pharmacological inhibition of SPHK2 could be a strong anti-cancer strategy [20,67]. The gene discussed is SPHK2; the disease is cancer.